Sophie Cousin

机构：Institut Bergonié, Individual Differences

发表论文 300 篇 · 总被引 5317 次 · h-index 36

代表论文

• Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A (2025 · Journal of Thoracic Oncology · 被引 32)
• Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial (2025 · Nature Cancer · 被引 11)
• First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation (2025 · Journal of Clinical Oncology · 被引 9)
• Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial (2025 · The Lancet Oncology · 被引 9)
• Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis (2025 · Nature Cancer · 被引 8)
• Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (2025 · JTO Clinical and Research Reports · 被引 6)